7 employees
GamaMabs Pharma is a clinical-stage immuno-oncology company that developes optimized therapeutic antibodies for the treatment of cancer.
2013
$16M
from 3 investors over 3 rounds
Gamamabs Pharma raised $16M on December 15, 2015
Investors: Andera Partners, Inno Bio Ventures Sdn. Bhd. and iXO Private Equity